logo
    Screening and managing cannabis use: comparing GP’s and nurses’ knowledge, beliefs, and behavior
    22
    Citation
    32
    Reference
    10
    Related Paper
    Citation Trend
    Abstract:
    General practitioners (GPs) and nurses are ideally placed to address the significant unmet demand for the treatment of cannabis-related problems given the numbers of people who regularly seek their care. The aim of this study was to evaluate differences between GPs and nurses' perceived knowledge, beliefs, and behaviors toward cannabis use and its screening and management. This study involved 161 nurses and 503 GPs who completed a survey distributed via conference satchels to delegates of Healthed seminars focused on topics relevant to women and children's health. Differences between GPs and nurses were analyzed using χ2- tests and two-sample t-tests, while logistic regression examined predictors of service provision. GPs were more likely than nurses to have engaged in cannabis-related service provision, but also more frequently reported barriers related to time, interest, and having more important issues to address. Nurses reported less knowledge, skills, and role legitimacy. Perceived screening skills predicted screening and referral to alcohol and other drug (AOD) services, while knowing a regular user increased the likelihood of referrals only. Approaches to increase cannabis-related screening and intervention may be improved by involving nurses, and by leveraging the relationship between nurses and doctors, in primary care.
    Keywords:
    Health psychology
    Brief intervention
    Background: Vaping, including vaping cannabis, is increasing among adolescents. In this longitudinal study, we examined the relationship between vaping cannabis and frequency of cannabis use and related problems over 6 months among adolescents. Material and Methods: Data were from 233 participants (46.8% male, 93.1% African American, mean age = 16.4 years) reporting cannabis use. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) assessed frequency of past 30-day cannabis use and cannabis-related problems at baseline, 3- and 6-months post-baseline. We used latent growth curve modeling to compare vaping to non-vaping adolescents on trends in cannabis use frequency and ASSIST cannabis scores. Results: Adolescents who vaped cannabis (11.7%) had higher past 30-day frequency (mean = 17.89 days, SD = 10.49) of cannabis use at baseline compared to adolescents who had not vaped (mean = 12.1 days, SD = 10.93), but reported a significantly sharper decline in frequency of cannabis use (b = −0.34, p = 0.017). A significantly steeper decrease existed in the mean cannabis ASSIST scores for the vaping group than for the non-vaping group (b = −0.34, p = 0.014). Mean ASSIST scores on the cannabis subscale between the two groups were significantly different at 6-month follow-up (Vape mean = 6.00, SD = 8.12 vs. Non-vape mean = 9.6, SD = 9.39; p < 0.021). Conclusions: In a sample of cannabis-using adolescents, adolescents with experience vaping cannabis, compared to adolescents without vaping experience, on average reported sharper decreases in frequency of cannabis use and cannabis-related problems such as health or social problems.
    Marijuana smoking
    Tetrahydrocannabinol
    Illicit drug
    Effects of cannabis
    Cannabis Dependence
    Delta-9-tetrahydrocannabinol
    Abstract Introduction Cannabis legalisation was enacted on 17 October 2018 in Canada. Accordingly, the effects of cannabis legalisation on patterns of cannabis consumption were examined among adolescents, including on cannabis initiation, any cannabis use, daily cannabis use and cannabis dependence. Methods Data from a biennial population‐based, cross‐sectional survey of students in Ontario were pooled in a pre‐post design (2001‐2019; N = 89,238). Participants provided self‐reports of cannabis initiation, any cannabis use, daily cannabis use and cannabis dependence. Long‐term trends in these patterns of cannabis consumption over two decades of observation were characterised to provide a broader context of usage. The effects of cannabis legalisation on patterns of cannabis consumption were quantified using logistic regression analyses. Results Long‐term trends over the two decades of observation indicated that cannabis initiation decreased and then increased ( p = 0.0220), any cannabis use decreased and daily cannabis use decreased ( p < 0.0001 and p = 0.0001, respectively) and cannabis dependence remained unchanged ( p = 0.1187). However, in comparisons between the pre‐cannabis legalisation period (2001–2017) and the post‐cannabis legalisation period (2019), cannabis legalisation was not associated with cannabis initiation (odds ratio; 95% confidence interval 1.00; 0.79–1.27), but it was associated with an increased likelihood of any cannabis use (1.31; 1.12–1.53), daily cannabis use (1.40; 1.09–1.80) and cannabis dependence (1.98; 1.29–3.04). Discussion and Conclusions Cannabis legalisation was not associated with cannabis initiation, but it was associated with an increased likelihood of any cannabis use, daily cannabis use and cannabis dependence.
    Cannabis Dependence
    Effects of cannabis
    Dronabinol
    Citations (7)
    Abstract In 2019 an estimated 200 million people aged 15-64 used cannabis, making cannabis the most prevalent illicit substance worldwide. The last decade has seen a significant expansion in the cannabis vaporiser market, introducing cannabis vaporisation as a common administration method alongside smoking and ingestion. Despite reports of increased prevalence of cannabis vaporisation there has been little research into the use of these devices. To remedy the current dearth of data in this area this study utilised an anonymous online survey of individuals who self-reported past cannabis vaporisation. The respondents (N=557) were predominantly young (<35 years) and male. Most (91.4%) stated they had ever vaped dry herb cannabis, 59.1% reported vaporisation of cannabis oil or liquids, and 34.0% reported vaporisation of cannabis concentrates. This study identifies the types of vaporisation devices (including brands and models) employed by cannabis vapers, as well as the vaporisation temperatures and puff durations commonly used for dry herb, cannabis liquids and cannabis concentrates. To the best of our knowledge, this is the first time the usual operating temperatures of these vaporisation devices and user specific consumption patterns such as puff duration have been reported for cannabis vaping. This information will allow for more realistic experimental conditions in research settings.
    Cannabis Dependence
    Effects of cannabis
    The prevalence of cannabis use in Australia has increased in the last few years, prompting some to argue that the prohibition against cannabis is both costly and ineffective and should be lifted. Surveys designed to evaluate the effect of reducing or eliminating sanctions for cannabis use, however, have been more concerned about the effect of cannabis law reform on the number of new cannabis users than about its effect on cannabis consumption among existing users. This is a serious oversight because most of the risks associated with cannabis are associated with regular rather than occasional use of the drug. The present research was designed to assess some of the potential effects of lifting the prohibition against cannabis use.The study results suggest that, while the illegal status of cannabis does act to limit its use, it is not a major factor in decisions about whether to use cannabis or to cease using it. Prohibition does, however, appear to limit consumption among existing cannabis users and particularly among those who use the drug on a weekly basis or more frequently.
    Consumption